Biogen Seeks FDA Approval for New Alzheimer’s Drug
Biogen is planning to file for U.S. regulatory approval for its Alzheimer’s treatment aducanumab after data from more patients in two discontinued studies showed that the drug improved cognition at
Biogen Seeks FDA Approval for New Alzheimer’s Drug Read More »